BACKGROUND: A 776C-->G variant (dbSNP ID: rs1801198) in the transcobalamin gene (TCN2; MIM# 275350) decreases the cellular and plasma concentration of transcobalamin and thereby influences the cellular availability of vitamin B(12). OBJECTIVE: To evaluate the worldwide prevalence of this variant and its association with homocysteine plasma level. METHODS: The study was performed in 1433 apparently healthy subjects, including Afro-Americans and Afro-Africans and in 251 Afro-Africans participants with severe malaria. RESULTS: The frequencies of the 776G allele were the highest in China (0.607; 95% CI 0.554 to 0.659), low in West Africa (Bénin and Togo, 0.178; 0.154 to 0.206), and intermediate in France (0.445; 0.408 to 0.481), Italy (0.352; 0.299 to 0.409), Morocco (0.370; 0.300 to 0.447) and Mexico (0.374; 0.392 to 0.419). The 776G genotype was more frequent in Afro-Americans from New York (16.7; 8.4 to 30.7) and in Afro-African patients with severe malaria (6.0%; 95% CI 3.7 to 9.6) than in healthy Afro-African volunteers (p = 0.0004 and p = 0.033, respectively), while no difference was observed for MTHFR 677TT and 677T alleles. A disequilibrium of TCN2 genotype distribution was recorded in patients with severe malaria, with a twofold higher GG genotype than expected (p = 0.010). An association between the TCN2 polymorphism and homocysteine was observed only in Mexico and France, the two countries with the highest rate of low plasma concentration of vitamin B(12) (<100 pmol/l). CONCLUSION: Given the dramatic heterogeneity of the 776G allele frequency worldwide, this polymorphism may be prone to a selective pressure or confers an evolutionary advantage in confronting environmental factors, one of which is malaria.
BACKGROUND:A 776C-->G variant (dbSNP ID: rs1801198) in the transcobalamin gene (TCN2; MIM# 275350) decreases the cellular and plasma concentration of transcobalamin and thereby influences the cellular availability of vitamin B(12). OBJECTIVE: To evaluate the worldwide prevalence of this variant and its association with homocysteine plasma level. METHODS: The study was performed in 1433 apparently healthy subjects, including Afro-Americans and Afro-Africans and in 251 Afro-Africans participants with severe malaria. RESULTS: The frequencies of the 776G allele were the highest in China (0.607; 95% CI 0.554 to 0.659), low in West Africa (Bénin and Togo, 0.178; 0.154 to 0.206), and intermediate in France (0.445; 0.408 to 0.481), Italy (0.352; 0.299 to 0.409), Morocco (0.370; 0.300 to 0.447) and Mexico (0.374; 0.392 to 0.419). The 776G genotype was more frequent in Afro-Americans from New York (16.7; 8.4 to 30.7) and in Afro-African patients with severe malaria (6.0%; 95% CI 3.7 to 9.6) than in healthy Afro-African volunteers (p = 0.0004 and p = 0.033, respectively), while no difference was observed for MTHFR 677TT and 677T alleles. A disequilibrium of TCN2 genotype distribution was recorded in patients with severe malaria, with a twofold higher GG genotype than expected (p = 0.010). An association between the TCN2 polymorphism and homocysteine was observed only in Mexico and France, the two countries with the highest rate of low plasma concentration of vitamin B(12) (<100 pmol/l). CONCLUSION: Given the dramatic heterogeneity of the 776G allele frequency worldwide, this polymorphism may be prone to a selective pressure or confers an evolutionary advantage in confronting environmental factors, one of which is malaria.
Authors: G Pepe; O Camacho Vanegas; B Giusti; T Brunelli; R Marcucci; M Attanasio; O Rickards; G F De Stefano; D Prisco; G F Gensini; R Abbate Journal: Am J Hum Genet Date: 1998-09 Impact factor: 11.025
Authors: F Namour; M Guy; I Aimone-Gastin; M de Nonancourt; N Mrabet; J L Guéant Journal: Biochem Biophys Res Commun Date: 1998-10-29 Impact factor: 3.575
Authors: Deborah A Swanson; Faith Pangilinan; James L Mills; Peadar N Kirke; Mary Conley; Andrea Weiler; Tiffany Frey; Anne Parle-McDermott; Valerie B O'Leary; Rebecca R Seltzer; Kathryn A Moynihan; Anne M Molloy; Helen Burke; John M Scott; Lawrence C Brody Journal: Birth Defects Res A Clin Mol Teratol Date: 2005-04
Authors: Emile K Amouzou; Nicodème W Chabi; Charles E Adjalla; Rosa M Rodriguez-Guéant; François Feillet; Christian Villaume; Ambaliou Sanni; Jean-Louis Guéant Journal: Am J Clin Nutr Date: 2004-04 Impact factor: 7.045
Authors: Simon M Collin; Chris Metcalfe; Tom M Palmer; Helga Refsum; Sarah J Lewis; George Davey Smith; Angela Cox; Michael Davis; Gemma Marsden; Carole Johnston; J Athene Lane; Jenny L Donovan; David E Neal; Freddie C Hamdy; A David Smith; Richard M Martin Journal: Int J Mol Epidemiol Genet Date: 2011-11-28
Authors: Aristea Binia; Alejandra V Contreras; Samuel Canizales-Quinteros; Victor Acuña Alonzo; M Elizabeth Tejero; Irma Silva-Zolezzi Journal: Genes Nutr Date: 2014-08-09 Impact factor: 5.523